Filing Flows › Biolife Solutions (BLFS) › Q1 2026 › vs Q4 2025
Biolife Solutions (BLFS) Q1 2026 vs Q4 2025 (quarter over quarter)
Biolife Solutions's revenue rose $8.7M (+46%) from $18.8M in Q4 2025 to $27.5M in Q1 2026. Operating margin 0.1% against 7.2% (-7.1 pts).
Biolife Solutions, Q1 2026: revenue $27.5M (+25% year over year), operating margin 0.1%, net earnings $1.2M, operating cash flow −$491K. The chart draws each line against Q4 2025, the increases inside each band.
Margins
| Q1 2026 | Q4 2025 | Change | |
|---|---|---|---|
| Operating margin | 0.1% | 7.2% | -7.1 pts |
| Net margin | 4.3% | 58.9% | -54.6 pts |
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $27.5M | $18.8M | $8.7M | +46% |
| Other income, net | $1.2M | $9.6M | −$8.3M | -87% |
| Operating profit | $27K | $1.3M | −$1.3M | -98% |
| Pre-tax earnings | $1.2M | $10.9M | −$9.6M | -89% |
| Sales & marketing | $2.5M | $2.0M | $533K | +27% |
| General & admin | $12.2M | $10.6M | $1.7M | +16% |
| Other operating costs | $85K | $4.9M | −$4.8M | -98% |
| Net earnings | $1.2M | $11.1M | −$9.9M | -89% |
| Income tax | $62K | −$173K | $235K | — |
| Operating cash sources | $6.9M | $13.5M | −$6.6M | -49% |
| Depreciation & amortization | $374K | $261K | $113K | +43% |
| Share-based compensation | $4.8M | $7.1M | −$2.3M | -32% |
| Cash used in operations | $491K | −$4.9M | $5.4M | — |
| Working capital & other | $6.9M | $13.5M | −$6.6M | -49% |
Questions
How much did Biolife Solutions's revenue grow quarter over quarter in Q1 2026?
Biolife Solutions's revenue rose $8.7M (+46%) from $18.8M in Q4 2025 to $27.5M in Q1 2026. Operating margin 0.1% against 7.2% (-7.1 pts).